Forest Enters Antibiotic Field Through Faropenem Licensing Deal
Forest will oversee U.S. sales and marketing efforts for the pending antibiotic Orapem under an agreement with Replidyne.
Forest will oversee U.S. sales and marketing efforts for the pending antibiotic Orapem under an agreement with Replidyne.